Related by context. All words. (Click for frequent words.) 58 pertuzumab 58 lenalidomide Revlimid R 58 Tesmilifene 58 Pertuzumab 58 radiation chemoradiation 58 refractory metastatic 57 Chemoradiation 57 Oncotype 56 multitargeted 56 relapsed MM 56 CRLX# 56 standard chemotherapy regimens 56 Apatone 56 trastuzumab Herceptin R 56 thalidomide Thalomid 56 proprietary translational medicine 55 DNA methylation markers 55 antiangiogenic agents 55 evaluating tivozanib 55 OMP #M# 55 CYT# potent vascular disrupting 55 neratinib 55 PSMA ADC 55 Platinol ® cisplatin 54 gefitinib Iressa 54 Cardiotoxicity 54 PORxin TM platforms 54 HER2 positive breast 54 deCODE ProstateCancer TM 54 radezolid 54 prospective multicentre 54 Taxanes 54 studies evaluating satraplatin 54 Ceplene/IL-2 54 Xelox 54 prospective observational studies 54 Phase #/#a trial 54 Xanafide 54 ixabepilone 54 intraperitoneal therapy 53 erlotinib Tarceva ® 53 sorafenib tablets 53 anti angiogenic drugs 53 bortezomib Velcade R 53 acyclovir Lauriad R 53 XmAb# 53 Deforolimus 53 BR.# 53 antihormonal 53 therapeutic regimens 53 Onconase 53 Panzem R NCD 53 FOLFOX6 chemotherapy regimen 53 viral kinetics 53 INxin TM 53 DEB# 53 EGS# 53 HuLuc# 53 intra arterial chemotherapy 53 KRAS status 52 preclinically 52 EOquin TM phase 52 paclitaxel Taxol 52 GVAX Pancreas Vaccine 52 CeaProve R 52 olaparib 52 Bayer HealthCare Onyx Pharmaceuticals 52 K ras mutations 52 paclitaxel Taxol ® 52 #F FDG PET 52 gemcitabine Gemzar ® 52 chemopreventive agents 52 transgenic mouse models 52 PMX # heptagonist 52 enzastaurin 52 PhG alpha 1 52 Combination therapy 52 Elotuzumab 52 transcranial Doppler ultrasound 52 Quinamed 52 YONDELIS 52 INCB# [001] 52 metastatic colorectal 52 Myocet 52 haematologic 52 Locked Nucleic Acid LNA 52 Hepatocellular Carcinoma HCC 52 MAGE A3 ASCI 52 cognitive behavioral therapies 52 molecularly targeted therapies 52 RhuDex R 52 evaluating mipomersen 51 TRISENOX 51 EUS FNA 51 Dendreon Provenge 51 FDG-PET/CT 51 trastuzumab DM1 T DM1 51 mda 7 51 HCV SPRINT 51 ALK inhibitors 51 Allovectin 7 51 Tarvacin 51 Tarceva TM 51 KRAS mutation 51 KRAS oncogene 51 elacytarabine 51 delafloxacin 51 BEZ# 51 IMC #B 51 Skinvisible receives 51 preclinical efficacy 51 concurrent ITP 51 LungSign TM 51 evaluating satraplatin 51 proteomic biomarkers 51 CTAP# Capsules 51 OncoVEX 51 proteasome inhibitor 51 GW# [003] 51 microRNA expression 51 Fludara ® 51 Symadex 51 Cytolin R 51 antitumour 51 sunitinib malate 51 Phase III Trials 51 BRAF inhibitor 51 PROSTVAC VF 51 nanoviricides 51 HGS ETR1 51 AVOREN 51 PROSTVAC TM 51 demonstrated antitumor activity 51 alvespimycin 51 AF ablation procedures 50 BRIM2 50 dissolving clots 50 clinicopathological 50 Proellex TM 50 ThermoDox R 50 Oncotype DX Recurrence Score 50 Rigel R# 50 Tesetaxel 50 Urocortin 2 50 ganetespib 50 NEUGENE 50 Carfilzomib 50 histologies 50 RhuDex ® 50 AChE inhibitors 50 tubulin inhibitor 50 BCX# 50 Carotid artery stenting 50 Tykerb lapatinib 50 custirsen 50 PROLARIS 50 pediatric malignancies 50 Targretin capsules 50 farletuzumab 50 Tumor Response 50 MGd 50 virotherapy 50 lipid nanoparticles LNPs 50 cyclophilin inhibitors 50 PRESEPT study 50 next generation URAT1 50 susceptibility loci 50 vidofludimus 50 perfusion MRI 50 Enzastaurin 50 MMP inhibitors 50 anastrozole Arimidex 50 protein kinase inhibitor 50 predictive biomarkers 50 Relapsed Multiple Myeloma 50 Oncotype DX colon cancer 50 Anticalins ® 50 OncoVEX GM CSF 50 antiangiogenesis 50 Aprela 50 PI3K/Akt pathway inhibitor 50 deforolimus 50 docetaxel Taxotere R 50 blinded randomized placebo controlled 50 PEG SN# 50 Immunotherapeutic 50 Preclinical Study 50 RAV# 50 DGAT1 inhibitors 50 APEX PD 50 huC# DM4 50 DermaVir 50 enzyme immunoassay EIA 50 investigational protease inhibitor 50 metaglidasen 50 galiximab 50 Phase III Clinical Trials 49 chemo immunotherapy 49 adoptive immunotherapy 49 Anticalins 49 OncoVex 49 PhenoSense GT 49 Glufosfamide 49 Factor Xa inhibitor 49 Cholesterol Levels SPARCL 49 vascular disrupting agents 49 SinuNase TM 49 CeaProve ® 49 Angiolix 49 CD# CEA 49 vivo preclinical 49 IDH1 mutation 49 genomic biomarker 49 hypofractionated 49 Phase IIa trials 49 intensive lipid lowering 49 DCE MRI 49 phase IIb study 49 novel VDA molecule 49 Immunohistochemistry 49 Archexin 49 ALTTO 49 Prolongs Survival 49 CBLC# 49 Gastrointestinal Stromal Tumors 49 fosbretabulin 49 antiplatelet therapies 49 immunotherapeutic approaches 49 miRNA expression patterns 49 Xcellerated T Cells 49 Vaxfectin 49 Genes Identified 49 Lenocta 49 midstage clinical 49 Triapine R 49 Traficet EN 49 inactivated influenza vaccines 49 biologic DMARDs 49 antibiotic ceftriaxone 49 PEGylated 49 topical NSAIDs 49 methylation markers 49 percutaneous biopsy 49 MRgFUS 49 oral picoplatin 49 Phase IIB 49 MTP inhibitors 49 PROCHYMAL 49 VEGF inhibitors 49 HCV RESPOND 2 49 chemoresistant 49 DCVax R 49 HER2 overexpression 49 receptor tyrosine kinase inhibitor 49 liposome encapsulated 49 CYT# vascular disrupting 49 antiandrogens 49 immunosuppressive regimens 49 velafermin 49 ospemifene 49 anti angiogenic therapy 48 Neulasta ® 48 Sphingomab 48 mGluR2 NAM 48 TGFBR1 * 6A 48 Alferon N 48 RE LY trial 48 danoprevir 48 maximally tolerated dose 48 Oncotype DX breast cancer 48 CORT # 48 Thiovir 48 lexidronam injection 48 CCX# 48 Pharmos proprietary 48 small molecule defensin 48 Thalomid ® 48 HGS# 48 Thorough QT 48 Inhaled corticosteroids 48 Panzem R 48 tremelimumab 48 Aplidin R 48 KRAS BRAF 48 vitro experiments 48 OXi# 48 Exherin TM 48 druggable targets 48 Androgen deprivation therapy 48 deCODE AF TM 48 DermaVir Patch 48 Telatinib 48 exon skipping 48 colorectal lung 48 pharmacokinetic PK study 48 tanespimycin 48 Safinamide 48 Psoraxine R 48 meta analytic 48 LungExpress Dx 48 lesinurad 48 therapeutic monoclonal antibody 48 MKC# MKC# PP 48 synthetic cannabinoid library 48 Interferon beta 48 GI motility disorders 48 PMX # antibiotic 48 Cloretazine ® 48 metastatic androgen independent 48 quantitative cytology 48 meta regression 48 recurrent metastatic ovarian cancer 48 treating uterine fibroids 48 cancer immunotherapies 48 intradermal injection 48 PrevOnco ™ 48 R sorafenib tablets 48 R Bortezomib 48 microRNA biomarkers 48 bazedoxifene conjugated estrogens 48 Acute myelogenous leukemia 48 lymphatic mapping 48 DAC Blockers Platform 48 assessing T DM1 48 pretargeting 48 convenient dosing regimens 48 Therapy HAART 48 PrevOnco 48 genomic profiling 48 massively parallel sequencing 48 PANVAC VF 48 Phase IIb clinical trials 48 CHAMPION PCI 48 Haptoglobin 48 SYN# 48 figitumumab 48 ZACTIMA TM ZD# 48 pharmacological approaches 48 VALOR trial 48 Anthrax Toxin 48 silico prediction 48 chemotherapy molecularly targeted 48 Mutational 48 ß blockers 48 Fragment Library 48 reverse vaccinology 48 prostate cancer PCa 48 midstage clinical trials 48 Vaxfectin TM 48 tramiprosate Alzhemed TM 48 NABTT 48 PLX MS 47 Viprovex TM 47 rNAPc2 47 GAP #B# 47 MVA BN R 47 immunohistochemical 47 cadmium alloys 47 kidney urologic 47 Surgical resection 47 Pre implantation genetic 47 pharmacogenetic testing 47 Carotid Revascularization Endarterectomy vs. 47 Azedra ™ 47 epithelial tumors 47 miRview ™ mets 47 ONCONASE R 47 ImmunoVEX HSV2 47 T#I [002] 47 Alkaline Phosphatase 47 genomewide association study 47 Vitaxin 47 Triptans 47 myelofibrosis polycythemia vera 47 TKB# 47 BioMAP ® 47 HCV polymerase inhibitors 47 Phase Ib clinical 47 BGC# 47 HTS assay 47 Tarvacin Anti Viral 47 RGB # 47 IL#B 47 AEG# 47 adeno associated viruses 47 Oncotype DX ® 47 droperidol 47 Active Anti Retroviral 47 NOD mouse 47 sCJD 47 treating neuropathic pain 47 molecular cytogenetic 47 CGEN # 47 NanoCrystal Technology 47 Luminex xMAP technology 47 FTIs 47 functional neuroimaging 47 PARP inhibition 47 anticoagulant reversing agent 47 LightCycler ® Instrument 47 Phase Ib II 47 CA4P 47 mutational analysis 47 Trandolapril 47 candidates Azedra TM 47 multivariate Cox 47 oral proteasome inhibitor 47 BRAF mutated 47 brivanib 47 UVIDEM 47 Hedgehog inhibitor 47 Canvaxin TM 47 Insulin detemir 47 lung pancreatic 47 KRAS variant 47 Trastuzumab DM1 47 Truvada tablets 47 Phase 1b clinical trials 47 Phase #b/#a clinical 47 CBAS TM 47 OvaRex R 47 Edurant 47 AdVac ® 47 BioMAP ® Systems 47 nonpharmacological 47 delipidation 47 Lisofylline LSF 47 NOX E# 47 inhibit replication 47 AVERROES 47 Sentinel node biopsy 47 TORISEL TM 47 vivo validation 47 phase Ib 47 ocular formulation 47 molecular biomarkers 47 NB S# strontium malonate 47 topical antifungal 47 Intravail ® 47 BHT DNA 47 Selective Electrochemical Tumor Ablation 47 SinuNase ™ 47 xTAG RVP 47 AAG geldanamycin analog 47 OvaRex ® MAb 47 Excellarate TM 47 oncolytic virus therapies 47 Scancell 47 neovascular diseases 47 Panzem NCD 47 retaspimycin 47 GFT# 47 SVMs 47 ELISPOT 47 investigational monoclonal antibody 47 TAFA# 47 cardiotoxic 47 AstraZeneca PLC Arimidex 47 clinically validated 47 Anavex #-# 47 Septin9 47 HGS ETR1 mapatumumab 47 melanoma basal cell 47 LungAlert TM 47 dendritic cell vaccine 47 ChemoFx 47 sarcosine 46 Neugene 46 Vidaza R 46 cytotoxic agents 46 DIRECT Trial 46 multigene expression test 46 REVIVE Diabetes 46 Corus CAD 46 radiosensitive 46 TRAIL receptor antibodies 46 evaluating Nexavar 46 univariate 46 balloon hem minidresses 46 NAET 46 squalamine 46 PF # [002] 46 Solazed TM 46 Allopurinol 46 monovalent vaccine 46 ThermoDox ® clinical 46 PLX STROKE targeting 46 NS#/#A protease 46 BACcel 46 basal cell carcinoma squamous 46 BRAF inhibitors 46 prognostic markers 46 vitespen 46 cognitive inhibition 46 DVT prophylaxis 46 biomarker identification 46 Zemplar Capsules 46 conjoint analysis 46 siRNA knockdown 46 CCR5 antagonist 46 IMC A# 46 CT angiograms 46 valvular heart 46 LEAPS TM 46 pancreatic prostate 46 molecularly targeted 46 Bcr Abl inhibitors 46 cotrimoxazole prophylaxis 46 metabonomics 46 Bacille Calmette Guérin BCG 46 ADVEXIN therapy 46 Mass Spectrometry MS 46 organophosphorus compounds 46 immune modulatory 46 antiviral therapies 46 QUADRAMET R 46 HERmark 46 undruggable targets 46 Curaxin CBLC# 46 ORACLE MS 46 SurModics Bravo 46 miRNA biomarkers 46 NMP# assay 46 Lofexidine 46 Imetelstat 46 Biomerk Tumorgraft 46 Photodynamic therapy 46 steroid inhalers 46 anti PlGF 46 MGCD# [001] 46 recombinant PSMA vaccine 46 Cholinesterase Inhibitors 46 ongoing Phase IIIb 46 MammaPrint R 46 Combivir Kivexa 46 Ceflatonin R 46 HIF PH inhibitors 46 Dr. Pasinetti 46 metabolomic profiles 46 TBC M4 46 elotuzumab 46 vaccine GMK 46 TPI ASM8 46 FluCide 46 cicletanine 46 therapies ACTs 46 OnDose TM 46 noninvasive outpatient 46 motesanib 46 Actilon 46 tumor suppressors cytokines 46 Valproic acid 46 GV# [001] 46 Solazed 46 pegylated alpha interferon 46 testing huN# DM1 46 sDNA 46 CAMMS# 46 nCounter Analysis System 46 ERBITUX Cetuximab 46 colon pancreas 46 NITD# 46 Troxatyl 46 BCR ABL inhibitors 46 Trofex TM 46 human microdosing 46 including eniluracil ADH 46 PNT# 46 gastrointestinal disorders ATI 46 Hemopurifier TM 46 INSPIRE Trial Phase III 46 mertansine 46 Solid Tumors 46 Evaluation Program CTEP 46 conditional logistic regression 46 AvalonRx R 46 phase IIb 46 potent cytotoxic 46 chimeric protein 46 ARRY # 46 MCSP respectively 46 synthetic peptides 46 TELINTRA 46 adecatumumab 46 CEQ# 46 antitumor effect 46 cervical precancerous lesions 46 BioLeap 46 Lu AA# 46 budesonide foam 46 inhibit EGFR 46 H2 antagonists 46 Phase IIa proof 46 LNP formulations 46 CCR5 inhibitor 46 pharmacokinetic pharmacodynamic PK PD 45 beta secretase inhibitors 45 colorectal bladder 45 multivariate logistic regression 45 nonpharmacologic 45 multicenter trials 45 recombinant vaccines 45 Phase IIb trials 45 optogenetic 45 sapacitabine CYC# 45 isotype 45 bioinformatic approaches 45 malignant mesothelioma Alfacell 45 ATAC Arimidex Tamoxifen Alone 45 dirucotide MBP# 45 Litx 45 active IgG1 monoclonal 45 lymphoma multiple myeloma 45 highly immunogenic 45 solithromycin 45 chemometric 45 limb sparing 45 multicenter Phase II 45 Phase Ib study 45 GLP toxicology studies 45 DiLA2 45 Agilent microarrays 45 immunohistochemical staining 45 pharmacotherapeutic 45 Anticalins R 45 MET amplification 45 Phase #/#a 45 nanoviricide drug 45 Cloretazine R VNP#M 45 PDE# inhibitors 45 Procalcitonin 45 anti amnesic 45 prophylactic preventive 45 Phase III metastatic melanoma 45 CINtec ® PLUS 45 Kevetrin ™ 45 chemotherapeutic 45 Sanger Sequencing 45 Targeted Chemotherapy 45 SANCTURA XR NEBIDO 45 GEM OS2 45 rheumatoid arthritis inflammatory bowel 45 retrospective observational 45 Cancer Vaccines 45 treating enlarged prostates 45 evildoers Fischer 45 midstage trials 45 antiplatelets 45 endothelin antagonists 45 Completes Patient Enrollment 45 vasopressors 45 IIa clinical 45 rocket launchers Abdel Salam 45 Monoclonal Antibodies 45 European Sepsis Trial 45 telomerase therapeutic 45 adjuvant therapies 45 nanoviricide 45 neurophysiologic 45 VKORC1 45 AML MDS 45 EXPLORE Xa 45 multicenter Phase 45 VeraTag 45 colorectal ovarian 45 Septin9 biomarker 45 nomograms 45 EKC Cide 45 foam sclerotherapy 45 Photodynamic therapy PDT 45 CVx ChannelVision Expo 45 Micromet BiTE antibodies 45 Brentuximab Vedotin SGN 45 dimebon latrepirdine 45 genetic loci 45 BiTE 45 targeting miR 45 Poisson regression 45 Initiates Enrollment 45 Multimodality 45 diagnostic biomarker 45 Forrester TEI 45 TILLING 45 initiate multicenter 45 ICON7 45 Hormonal therapy 45 Phase III Pivotal 45 multicenter Phase III 45 hybridoma 45 IRX 2 45 3D conformal radiation 45 SELDI TOF MS 45 JAK inhibitors 45 Phase 2b Trial 45 Hormone Refractory Prostate Cancer 45 oral antiviral 45 ZFP Therapeutics 45 causative mutations 45 Nektar proprietary 45 positional cloning 45 neuropathologic 45 COSIRA trial 45 Allovectin 7 R 45 Empatic ™ 45 aurora kinase 45 antibiotic regimens 45 gastrointestinal stromal 45 lipid nanoparticle LNP 45 microdissection 45 radionuclide therapy 45 magnetic resonance spectroscopy MRS 45 molecular biomarker 45 Alzhemed TM 45 Surgical excision 45 ALS #-# 45 Bayesian methods 45 Phase 1a clinical 45 Brussels THR 45 Replikins 45 miRview TM mets 45 taxane derivative 45 curable cancers 45 Bayesian statistical 45 differentially expressed proteins 45 RapidChek SELECT 45 favorable pharmacokinetic profile 45 ovulation inducing 45 progressive metastatic prostate 45 throughput RNAi 45 pentadentate logo R 45 MKC# MT 45 Optimata 45 pancreatic colon 45 Multiple logistic regression 45 4SC AG ISIN DE# 45 antagomirs 45 R#/MEM # 45 PXD# 45 RDTs 45 AMPK activators 45 HCV NS5B polymerase 45 Shortened telomeres 45 CytoSure 45 products MKC# PP 45 TRO# 45 florbetaben 45 novel tubulin binding 45 basal bolus insulin 44 JAK2 inhibitors 44 CellPort Technologies 44 prokinetic agent 44 solid tumors ZYBRESTAT 44 wore khaki fatigues 44 selective estrogen receptor modulator 44 prognostic biomarkers 44 Ceflatonin 44 EGFR HER2 44 microsatellite instability 44 CAPACITY trials 44 Beta catenin pathway 44 ProLindac 44 Cyclin E 44 Dacogen injection 44 genomewide association studies 44 dexpramipexole 44 Phase IIa clinical trials 44 AFFiRiS 44 Alequel ™ 44 CytoCore develops cost 44 phase III isavuconazole 44 ORAL Solo 44 eTag assays 44 immunohistochemistry IHC 44 durable pain palliation 44 ChIP chip 44 HAAH 44 antianginal 44 biophysical techniques 44 anticholinergic agents 44 transcriptional profiling 44 ZYBRESTAT fosbretabulin 44 p# antigen 44 preventing recurrences 44 benign prostatic hyperplasia enlarged 44 urologic surgeons 44 ACCLAIM II 44 multiple logistic regression 44 tPA antithrombotics anticoagulation therapy 44 Septin 9 44 Multivariate logistic regression 44 Phase Ib 44 angiotensin analog 44 druggable 44 genomewide 44 drug pipeline TAFA# 44 engineered RAP peptides 44 antisense inhibitors 44 fusion enhancers 44 dermatologic diseases 44 MDRD 44 potent suppressor 44 desorption electrospray ionization 44 masitinib 44 anti tumoral 44 Chemotherapy Improves 44 ENMD # 44 histologic diagnosis 44 preventing venous thromboembolism 44 KPCB portfolio 44 short acting bronchodilator 44 siRNA conjugates 44 ADME Tox 44 HIV AIDS neuropathic pain 44 GRNVAC1 44 immunohistochemical analysis 44 TLR7 agonist 44 Metabolomic 44 therapeutic radiopharmaceuticals 44 Avastin Erbitux 44 NP2 Enkephalin 44 comparative genomic hybridization 44 differentiating squamous 44 hMPV 44 Zinc Finger Nuclease 44 Kaplan Meier method 44 MDS AML 44 LungExpress Dx TM 44 CG# [003] 44 PIK3CA 44 pharmacogenetic tests 44 Epiphany Biosciences 44 Ampligen ® 44 Angio Seal Evolution 44 Fc gamma receptors 44 histone deacetylase HDAC 44 number NCT# ClinicalTrials.gov 44 sarcoma melanoma 44 pharmacological treatments 44 RT qPCR 44 Antigenics QS 44 CHEMSAS ® 44 Epidermal Growth Factor Receptor 44 SIRT1 activators 44 macular degeneration ischemic 44 NEUGENE antisense 44 anti CD# antibodies 44 catheter ablations 44 selective orally bioavailable 44 Shows Promise Against 44 IMiDs 44 GRNCM1 44 unique alkylating agent 44 EML4 ALK 44 multi analyte 44 Prosaptide 44 specialized Thermal Imaging 44 Solorel TM 44 QTinno TM 44 include ColorectAlert TM 44 factor Xa inhibitor 44 vemurafenib 44 QSAR 44 ELISpot 44 vascular disrupting agent 44 albiglutide 44 susceptibility gene 44 TELCYTA 44 Pharmos pipeline 44 convenient dosing regimen 44 TÎ ² 4 44 BiTE antibodies targeting 44 LTRAs 44 meta cognitive 44 DXL ™ 44 LymphoStat B belimumab 44 TLR antagonist 44 intranasal corticosteroids 44 ImmuKnow assay 44 oral transmucosal 44 esophageal cancer rectal 44 ALTROPANE 44 pulmonary angiography 44 AKT inhibitor 44 LC MALDI 44 ArQule Kinase Inhibitor Platform 44 HGS ETR2 44 methylation profiling 44 CB1 antagonists 44 Protein Biomarkers 44 virosome 44 theranostic 44 automated microscopy 44 non pharmacological interventions 44 vitro assay 44 rheumatoid arthritis multiple sclerosis 44 catalytic antibodies 44 BCR ABL mutations 44 dSLIM 44 oncological outcomes 44 Yamanaka recipe 44 Anticalin ® 44 p# biomarker 44 Receptos 44 serological testing 44 ActiPix 44 AlloMap 44 MALDI MS 44 Curidium 44 torsemide ER 43 DVT prophylaxis cholesterol 43 #F FDG PET CT 43 proteomic analysis 43 IIa clinical trials 43 HDAC inhibition 43 bioluminescence imaging 43 Mendelian randomization 43 Vaccine Adjuvants 43 Eligen R Technology 43 cMET 43 TLR9 agonists 43 phase Ib clinical 43 NPRL2 43 ® bortezomib 43 neuroimaging techniques 43 metabolite identification 43 islet isolation 43 Trofile assay 43 EGFR inhibition 43 Angiocept 43 EarlyCDT Lung 43 genomic alterations 43 intravital 43 TASKi2 43 conserved sequences 43 Lymph node 43 Modrenal 43 ADMET Predictor TM 43 C#Y 43 preclinical toxicology 43 Mammostrat 43 hepatitis C protease inhibitor 43 peptide conjugated 43 pharmacologic approaches 43 XL# anticancer compounds 43 QRT PCR 43 somatic mutations 43 APTIMA HPV 43 MEK inhibitor RDEA# 43 iSONEP 43 Sanger sequencing 43 vaccines oncolytic virus 43 glial tumors 43 metabolite profiling 43 processors visit www.tensilica.com 43 XL# XL# 43 PLAC test 43 metabolomic profiling 43 Phase 2a clinical trials 43 quantitative PCR qPCR 43 Oncotype DX TM 43 TransVax ™ 43 AAV gene 43 genetic biomarkers 43 ON #.Na 43 Phase Ib clinical trials 43 Sphingomab TM 43 Randomized Phase 43 TREAT ALS 43 Theranostics 43 APC Targeting Technology 43 Cyclosert TM 43 OX1 43 monoclonal antibody therapeutics 43 LUMINATE pivotal clinical 43 product platforms AZX# 43 LDL cholesterol lowering 43 oral NSAIDs 43 rxRNA 43 HCV antiviral 43 tissue microarray 43 AKT1 mutation 43 Budesonide foam crofelemer 43 multiplexed assays 43 Liver biopsy 43 proprietary vascular protectant 43 BrachySil 43 treats acute lymphoblastic 43 MOZOBIL 43 #D#C# 43 transrectal ultrasound 43 monoclonal antibodies MAbs 43 prognostic indicators 43 TTR gene 43 Nylon Nickel 43 ASCO abstract 43 Feline ality program 43 ATL# [001] 43 durable remissions 43 candidate CRLX#